None listed
Conditions
Interventions
Others(Cosmetics(Moisturizer)) : Twice a day (morning and evening), once every 10ml for 4 weeks on the whole body including the lesion
Intervention group contains more than 12ml per day as it contains
Sponsors
Chung-Ang Univerisity Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Those diagnosed with atopic dermatitis from 19 to 60 years of age (Hanifin & Rajka diagnosis criteria) 2) Those with intermittent or persistent atopic dermatitis symptoms for at least 6 months (EASI(Eczema area and severity index) 10 or less) 3) Atopic patients with lesions in the lower limbs 4) Person who can follow-up during human body application test 5) Those who agree to participate in this clinical trial before signing the clinical trial and have signed the written consent
Exclusion criteria
Exclusion criteria: 1) In addition to atopic dermatitis, those who are suffering from skin diseases such as psoriasis or being treated 2) Within 4 weeks of screening, atopic dermatitis related to systemic antibiotics, systemic corticosteroids, immunosuppressive drugs or phototherapy 3) Those who received antihistamines within 2 weeks of screening 4) In order to improve atopic dermatitis within 1 week of screening time, took herbal medicine, health functional foods or used moisturizer. 5) Those with severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), heart disease (angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment) within 6 months of the screening date (except for cerebrovascular disease, In the case of a clinically stable subject, the test may be conducted by the examiner.) 6) People with psychiatric disorders such as depression, schizophrenia, alcoholism, drug addiction 7) Those who participated in similar clinical trials within 4 weeks of screening 8) Sensitive or allergic to raw materials 9) Those planning to become pregnant during pregnancy, during lactation, or within 3 months. 10) Any person who is found to be unfit for participation in the clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| trans-epidermal water loss;hydration state of the skin;EASI(Eczema area and severity index);DLQI(Dermatology Life Quality Index);VRS(Verbal Rating Scale) | — |
Secondary
| Measure | Time frame |
|---|---|
| Investigator's evaluation of the patient's improvement;Patient's evaluation of improvement | — |
Countries
Korea, Republic of
Contacts
Public ContactKwiyeong Park
Chung-Ang Univerisity Hospital
Outcome results
None listed